[Federal Register Volume 82, Number 162 (Wednesday, August 23, 2017)]
[Notices]
[Page 40009]
[FR Doc No: 2017-17871]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2013-N-0804; FDA-2013-N-1163; FDA-2013-N-1393; FDA-
2017-N-0084; FDA-2013-N-0731; FDA-2009-D-0008; FDA-2013-N-0868; FDA-
2013-D-0117; FDA-2016-N-2066; FDA-2017-N-0366]

Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, FDA PRA Staff, Office
of Operations, Food and Drug Administration, Three White Flint North,
11601 Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Premarket Notification Submission              0910-0120       6/30/2020
 510(k), Subpart E......................
Institutional Review Boards.............       0910-0130       6/30/2020
Patent Term Restoration, Due Diligence         0910-0233       6/30/2020
 Petitions, Filing, Format, and Content
 of Petitions...........................
Adverse Event Program for Medical              0910-0471       6/30/2020
 Devices (Medical Product Safety Network
 (MedSun))..............................
Eligibility Determination for Donors of        0910-0543       6/30/2020
 Human Cells, Tissues, and Cellular and
 Tissue-Based Products..................
Citizen Petitions and Petitions for Stay       0910-0679       6/30/2020
 of Action Subject to Section 505(q) of
 the Federal Food, Drug, and Cosmetic
 Act....................................
Guidance for Industry: Use of                  0910-0681       6/30/2020
 Serological Tests to Reduce the Risk of
 Transmission of Trypanosoma cruzi
 Infection in Whole Blood and Blood
 Components Intended for Transfusion....
Providing Information About Pediatric          0910-0762       6/30/2020
 Uses of Medical Devices Under Section
 515A of the Federal Food, Drug, and
 Cosmetic Act...........................
Certification of Identity for Freedom of       0910-0832       6/30/2020
 Information Act and Privacy Act
 Requests...............................
FDA Advisory Committee Membership              0910-0833       6/30/2020
 Nominations............................
------------------------------------------------------------------------

    Dated: August 18, 2017.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2017-17871 Filed 8-22-17; 8:45 am]
BILLING CODE 4164-01-P